LG
Therapeutic Areas
GPN Vaccines Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Gamma‑PN | Pneumococcal disease | Phase 1b |
Leadership Team at GPN Vaccines
TH
Tim Hirst, PhD
Chief Executive Officer
BF
Bruce Forrest, MD, PhD, MBA
Executive Chief Scientific Officer
PR
Paul Rolan, MBBS, MD, FRACP
Chief Medical Officer
JS
James Selkirk, FCA, MAICD
Chief Financial Officer
EK
Eve Kennedy, PhD
Vice President of Research and Development